The disconnect between the primary policy assumption underpinning the HTA Review, which is that products must be found safe and effective to be funded, demonstrates the extent of this MSAC outcome as a dangerous outlier.
-
Latest News
Auditor General launches audit of the procurement of onshore vaccine manufacturing facilities
The Auditor General has launched an audit to examine the effectiveness of the procurement and contract management of onshore vaccine manufacturing facilities.
-
Latest News The danger of this outlier is reflected in the disconnect with another policy process October 18, 2024
-
Latest News Pharmac seeking bids from suppliers of COVID-19 vaccines October 17, 2024“We’re looking at our approach to the funding, eligibility, and procurement of these vaccines to align with other vaccines that we fund and so we can continue keeping New Zealanders well,” said Pharmac chief executive Sarah Fitt.
-
Latest News New research uncovers Australian women are often reluctant to openly talk about menopause October 18, 2024New research shows that despite 82 per cent of women who have experienced menopause symptoms reporting impacts on their quality of life, many do not feel comfortable openly talking about what they are experiencing.
-
Podcast TrailblAZers speaks with primary care leader and researcher October 17, 2024In its latest episode, TrailblAZers speaks with Professor Charlotte Hespe AM, the head of General Practice and Primary Care Research at Notre Dame University's School of Medicine.
-
Latest News This has happened before and the response should be the same. No. October 17, 2024The government could save billions by circumventing the regulatory process and funding unapproved health interventions. Of course, it does not do this because of the obvious risk to patient safety and public confidence in the health system. Why now?
-
Latest News Disappointment as TGA goes public early on anticipated Alzheimer's therapy October 16, 2024The company said, "The outcome of the initial stage of an evaluation is not routinely communicated to the public whilst the TGA review process is ongoing, as it has been with lecanemab."
-
Latest News Biogen awarded 'Great Place to Work' certification for 2024 October 17, 2024David Henderson, the managing director for Biogen Australia and New Zealand, said, “This certification is more than just an accolade; it’s a reflection of our collective effort in creating a workplace where every voice is heard."
-
Latest News Commercial Eyes signs new AI-focused service agreement with Opyl October 17, 2024Tanya van der Wall, country managing director of Commercial Eyes, said, “We are excited to collaborate with Opyl and leverage their advanced AI capabilities to enhance the innovative data-driven insights we provide to our clients."
-
Latest News Funding unapproved copies would fundamentally change our system - it can't be allowed to happen October 16, 2024In debating the right and wrong of public hospitals cooking up copies of approved nuclear medicine therapies, this country must contemplate the broader consequences, including of any funding decision.
-
Latest News Mark Butler needs to understand the implications of accepting this recommendation October 15, 2024Health Minister Mark Butler is now considering funding a copy of a therapy, which the TGA has not and probably cannot lawfully consider, let alone approve.
-
Latest News AusBiotech calling on experts to become mentors for Industry Growth Program October 15, 2024AusBiotech is seeking mentors to guide and support up-and-coming startups as they navigate the commercialisation pipeline.
-
Latest News The reality is that what's rational for the industry is not rational for the government October 15, 2024The industry must eschew its longstanding habit of treating policy engagement like a game of 'half-court tennis' in which it assumes the government shares its objectives in reform processes. You are not hitting the ball to yourself.
-
Latest News On comparators, maybe demand the return of a policy already paid for? October 15, 2024Many might forget that Medicines Australia secured a significant reform of comparator pricing in its 2017 agreement with the government.
-
Latest News Government invests more in preparation for new avian flu strain October 14, 2024Health Minister Mark Butler said, “The interim Australian Centre for Disease Control is leading this work – and is very focused on ensuring we are as prepared as possible for any potential case of H5N1 avian influenza.”
-
Latest News The industry faces significant uncertainty, with barely three weeks until the US election October 14, 2024Democrat candidate Vice President Kamala Harris has announced a plan to dramatically expand the reforms implemented under the Inflation Reduction Act.
-
Latest News TGA signs Memorandum of Understanding with South Africa's regulator October 14, 2024The TGA and South African Health Products Regulatory Authority have signed a Memorandum of Understanding that aims to strengthen collaboration between the two health product regulators.
-
Latest News Dementia set to become Australia’s leading cause of death October 13, 2024Dementia Australia says the latest data from the Australian Bureau of Statistics highlights the urgent reality of dementia, revealing it is set to become the nation’s leading cause of death.
-
Latest News New report unveils hidden cost of Alzheimer’s disease, with cases to double by 2050 October 10, 2024Eli Lilly general manager Tori Brown said, “The report highlights a once in a generation opportunity to act on Alzheimer’s disease. It is good for patients, good for families and carers, good for health and aged care systems, and good for the economy."
-
Latest News Bondi Junction response must include increased funding and support for severe mental illness October 11, 2024“It’s important to acknowledge the size of the issue and enormity of the challenge. Approximately 880,000 Australians are now living with a severe and complex mental illness,” said Dirk Otto, the general manager of Boehringer Ingelheim Australia
Australian Biotech
-
Nyrada says it has completed safety studies ahead of Phase 1 clinical trial
October 16, 2024 -
AusBiotech calling on experts to become mentors for Industry Growth Program
October 15, 2024 -
Amplia Therapeutics CEO shares Prime Minister's Prize for Innovation
October 10, 2024 -
TGA approves new indication for Telix’s Illuccix to include patient selection for PSMA-targeted therapy
October 9, 2024 -
UQ spider venom heart drug moves into clinical trials
October 7, 2024
Other Health
-
Medibank expands four-day work week trial to 500 employees
October 9, 2024 -
Artrya submits application for Salix to the US FDA
September 30, 2024 -
'Australia’s child vaccination rates are world-leading. Our adult rates are not.'
August 19, 2024 -
HCF Research Foundation hosts roundtable to advance short stay joint replacements
July 22, 2024 -
Bupa Ventures to invest $20m to accelerate healthcare innovations
February 12, 2024
Latest Video
New Stories
-
New research uncovers Australian women are often reluctant to openly talk about menopause
October 18, 2024 - - Latest News -
The danger of this outlier is reflected in the disconnect with another policy process
October 18, 2024 - - Latest News -
Pharmac seeking bids from suppliers of COVID-19 vaccines
October 17, 2024 - - Latest News -
Auditor General launches audit of the procurement of onshore vaccine manufacturing facilities
October 17, 2024 - - Latest News -
This has happened before and the response should be the same. No.
October 17, 2024 - - Latest News -
Vitalis and Servita partner to lead healthcare digital transformation in Queensland
October 17, 2024 - - Latest News -
Commercial Eyes signs new AI-focused service agreement with Opyl
October 17, 2024 - - Latest News